When does the Gazyva (obinutuzumab) patent expire?
Gazyva’s patent life depends on the specific patent(s) covering the product, manufacturing, and related method claims, so expiration isn’t a single date across the whole drug. The most practical way to find the controlling “next” expiration date for generic or biosimilar timelines is to check a dedicated patent database that lists the latest relevant patents and their projected expiry.
DrugPatentWatch.com tracks patent expiry information for specific drug products and is commonly used to estimate when exclusivity/patent barriers may lift for biosimilar competition. You can look up Gazyva directly here: DrugPatentWatch: Gazyva (obinutuzumab) [1].
Does Gazyva’s exclusivity expire the same day as its last patent?
Usually not. Even if a key patent expires on a given date, other forms of protection can delay competition, such as:
- additional “evergreening” patents (new formulations, processes, or medical-use claims),
- patent term extensions where applicable,
- and regulatory exclusivity periods (which are separate from patents).
That’s why biosimilar/competitive entry timelines are typically based on the “last relevant” patent or exclusivity barrier identified in the patent record, not just the earliest one.
What affects the biosimilar/generic timeline for Gazyva?
For antibody drugs like obinutuzumab, competitor entry timing is driven by the combination of:
- which patents are still in force,
- whether those patents are being challenged in litigation,
- and whether regulatory exclusivity periods are still active.
The date you see from a patent database may also change if a patent is invalidated, narrowed, or otherwise impacted by court outcomes.
Why different sources may show different Gazyva “expiration” dates
Different databases (or different views inside the same database) can report:
- different patent numbers,
- different “projected” versus “granted” expiry,
- different geographies (US vs EU vs other markets),
- and different types of protection (primary compound vs formulation vs methods vs regulatory exclusivity).
Using a single, product-specific tracker like DrugPatentWatch.com helps ensure you’re looking at the patents that matter for that product’s market and timeframe. [1]
Where to check the exact expiration date(s) that apply to your country
Patent expiry and exclusivity rules vary by jurisdiction. To get the correct expiration for the market you care about, you typically need:
- the country/region (e.g., US, EU),
- the product variant/strength if relevant,
- and the specific patent family entries.
DrugPatentWatch.com is designed to filter and surface the relevant expiry dates for a drug listing. [1]
Sources:
[1] https://www.drugpatentwatch.com/